Today is good news putting a new NDA for approval Carlos spoke to the FDA they told him exactly what to do and they will expedite it for him because of the problem with the opioids at this time. I believe they like what they saw. I believe this is going to be very very lucrative. I’m a believer! 
L
Ok, so apparently, a link to a company PR gets removed (sigh). "...Adamis...plans to resubmit the NDA for ZIMHI to the FDA within the next 45 days..."
So, around beginning of June; we'll see how close the company comes to THAT target date. BTW, for those (including Carlo) who were predicting resubmission would take only a couple of months, a June NDA resubmission will be ~7 months since the most recent CRL.
c
I'm hoping for 1.8-2.1 price range. This company does have 3m in sales so it isn't simply a shot in the dark they do have products. At the bear minimum I think you can expect 30% returns from the current level this year.
Bullish
c
Almost 20 more institutions bought in
Bullish
T
What earnings! What kind of company as small as ADMP waits 3 1/2 months to announce their numbers unless they are terrible! The only hope we have is they announce the approval of Zimihi, but I wouldn’t hold my breath! Carlo is in no hurry to announce another report with a lot of promises and no action. Please retire Carlo while the company still might have value to another bio company!
m
some good news will be in soon. just bought the dips
J
They just filed a late notice filling with SEC Can someone explain what that means?
T
Attention all stockholders; Get ready for another earnings report showing another quarterly loss and many promises. Will it be 3-6 months more before we finally get Zimihi approved? Now that Sympeji is Walgreens how are sales going? Will we need to sell more stock to help finance future drug development? For years many of us have heard many hopes but no profit. Carlo you are running out of time and soon our money!Please do your job and get this company moving or sell it to someone that knows how to turn a profit!
Neutral
T
Adamis Pharmaceuticals Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) ("Company") announced today that in studies conducted at Galveston National Laboratory (GNL), University of Texas Medical Branch (UTMB) at Galveston, hamsters challenged with the virus that causes COVID-19 (SARS-CoV-2), resulted in decreased inflammation in the lungs of animals treated with Tempol compared to controls. This is the first data demonstrating that Tempol, a novel antioxidant, can reduce inflammation in animals given the virus (SARS-CoV-2) that causes COVID-19. The group plans on submitting the publication to a peer review journal.
P
Added 1500 shares today, only selling at 100% profit or more.
Bullish
S
will this stock reach 0.8 after earnings report this week?
O
I am starting to wonder ( based on posts on here ) that they see Zimhi as some kind of solution to the opioid crisis. Just to be clear - Zimhi is intended to revive people who have overdosed on more lethal drugs than present measures are unable to counteract. It may revive the recipient but does nothing for the underlying problem.
D
GLAL, ADMP NDA FDA approval. $5 $5 $5 tomorrow or FDA letter out soon
Bullish
c
Shorts I'm sorry to tell you this but if you bet against this in futures you are about to get burned real hard
Bullish
m
nice, finally green
D
save my post 30 min b4 market close high volume buy in.
Bullish
P
How come Andy and Bruce H post at the same time, with the same content, and the same strange non-sensical broken English? Don't you love coincidences?
s
avg volume 19.8 million. today's volume 800k. not much excitement here. maybe the FDA approval nonsense scared everybody off.
D
This is the game big boy invested, good earning + FDA approval. AH will be fun time. $3 or 5 AH. Big boy start loading up slowly now. GLAL. good company like that.
Bullish
d
I bought 300 hundred shares, I say in the next month we could see some gains
"...Adamis...plans to resubmit the NDA for ZIMHI to the FDA within the next 45 days..."
So, around beginning of June; we'll see how close the company comes to THAT target date.
BTW, for those (including Carlo) who were predicting resubmission would take only a couple of months, a June NDA resubmission will be ~7 months since the most recent CRL.
Can someone explain what that means?
SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) ("Company") announced today that in studies conducted at Galveston National Laboratory (GNL), University of Texas Medical Branch (UTMB) at Galveston, hamsters challenged with the virus that causes COVID-19 (SARS-CoV-2), resulted in decreased inflammation in the lungs of animals treated with Tempol compared to controls. This is the first data demonstrating that Tempol, a novel antioxidant, can reduce inflammation in animals given the virus (SARS-CoV-2) that causes COVID-19. The group plans on submitting the publication to a peer review journal.
not much excitement here. maybe the FDA approval nonsense scared everybody off.